NCT07436728 2026-03-27
A Study of TAK-505 in Adults With Solid Tumors
Takeda
Phase 1/2 Not yet recruiting
Takeda
Immorna Biotherapeutics, Inc.
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences